MTNB vs RF
Matinas BioPharma Holdings Inc (MTNB) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
RF does not have a complete income-statement cache yet.
MTNB currently screens at market cap $5.6M. RF currently screens at market cap $0.
Not investment advice. Open the MTNB and RF stock pages for the full models.
Not investment advice.